Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain
Top Cited Papers
Open Access
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (3) , 528-537
- https://doi.org/10.1016/j.ymthe.2005.11.015
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adeno-Associated Virus (AAV) Vectors in the CNSCurrent Gene Therapy, 2005
- Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous SystemMolecular Therapy, 2004
- Cross-Dressing the Virion: the Transcapsidation of Adeno-Associated Virus Serotypes Functionally Defines SubgroupsJournal of Virology, 2004
- Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad SpecificityJournal of Virology, 2002
- Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brainNeuroReport, 2001
- Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype VectorsMolecular Therapy, 2000
- Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of ExpressionHuman Gene Therapy, 1999
- Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in BrainHuman Gene Therapy, 1998
- Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous SystemExperimental Neurology, 1997
- Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vectorBrain Research, 1996